Insights

Global Equity Fund <i>- Developments in obesity drugs</i>

Jarrod Cahn recently discussed the subject of obesity drugs. He assessed their effect on the investment landscape, not only on the companies producing them but on other sectors and stocks that may be affected.

May 2024

Global Equity Fund <i>- Q&A</i>

With our Global Equity Fund recently reaching its 5-year anniversary, lead manager Jarrod Cahn shared his thoughts on the Fund's progress to date. He also discussed the strong performance and the current outlook amidst challenging market conditions.

November 2022

Dynamic Fund <i>- Q&A</i>

With Credo Dynamic recently reaching its 5-year anniversary, lead manager Rupert Silver recently shared his thoughts on the Fund's progress to date. He also discussed the strong performance, portfolio positioning and the current outlook amidst challenging market conditions.

August 2022